Epigral
- Market cap
- ₹ 3,838 Cr.
- P/E
- 14.3x
- P/B
- 1.79x
- 52-week range
- 807 – 1,729.9
- ROE
- 16%
- ROCE
- 15%
- Dividend yield
- 0.5%
- Debt / equity
- 0.26
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Epigral against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)14.3 against a typical 26.3: cheaper than most peers (1st = cheapest).34th of 129
- Sales growth+16.1% against a typical +25.9% from a year earlier.82nd of 112
- Profit growth−38.1% against a typical +42.4% from a year earlier.88th of 102
- Share price, 3 months−19.4% against a typical −5.5%.104th of 118
- Size₹ 3,837.5 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).26th of 126
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil AA | Stable | 13 Jul 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 13 Jul 2026 | Reaffirmed | Crisil AA | — | CRISIL | ₹ 970 Cr. | |
| 2 Jun 2026 | Reaffirmed | Crisil AA | — | CRISIL | ₹ 970 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 2 Nov 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 27 Jul 2026 | Financial Results | To consider and approve the Un-Audited Financial Results for the First quarter ended 30th June, 2026. |
| 2 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 30 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 10 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 2 Aug 2025 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended Jun 30, 2025 and Fund Raising |
| 5 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 478 | 472 | 525 | 651 | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 |
| Expenses | 370 | 349 | 369 | 475 | 448 | 463 | 454 | 443 | 455 | 494 | 568 | 526 |
| Operating Profit | 108 | 123 | 155 | 176 | 178 | 183 | 173 | 163 | 132 | 103 | 169 | 179 |
| OPM % | 23% | 26% | 30% | 27% | 28% | 28% | 28% | 27% | 23% | 17% | 23% | 25% |
| Other Income | 1 | 2 | 2 | 2 | 6 | 4 | 3 | 8 | 2 | 6 | −1 | 4 |
| Interest | 21 | 20 | 14 | 14 | 27 | 0 | 12 | 23 | 22 | 11 | 16 | 7 |
| Depreciation | 32 | 31 | 30 | 33 | 32 | 33 | 34 | 42 | 42 | 43 | 42 | 43 |
| Profit before tax | 56 | 74 | 113 | 131 | 124 | 154 | 131 | 107 | 70 | 55 | 111 | 133 |
| Tax % | 32% | 34% | 32% | 34% | 35% | 33% | 34% | −50% | 26% | 28% | 26% | 26% |
| Net Profit | 38 | 49 | 77 | 86 | 81 | 104 | 87 | 160 | 52 | 39 | 82 | 99 |
| EPS in Rs | 9.18 | 11.87 | 18.45 | 20.7 | 19.38 | 24 | 20.08 | 37.18 | 11.94 | 9.07 | 18.99 | 22.99 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 20%
- 5 Years
- 25%
- 3 Years
- 5%
- TTM
- 5%
- 10 Years
- 17%
- 5 Years
- 26%
- 3 Years
- −3%
- TTM
- −37%
- 10 Years
- —
- 5 Years
- 20%
- 3 Years
- 7%
- TTM
- —
- 10 Years
- 25%
- 5 Years
- 24%
- 3 Years
- 18%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Epigral | ₹ 909.00 | ₹ 3,838 Cr. | 14.3x | 1.8x | 16% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Maulik Patel
- Chairman of the Board, Managing Director
- Rakesh Agrawal
- Chief Financial Officer
- Gaurang Ghanshyam Trivedi
- Compliance Officer, Company Secretary
- Kaushal Soparkar
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.